Toll Free: 1-888-928-9744
Published: Feb, 2014 | Pages:
30 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Iroko Pharmaceuticals, LLC - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Iroko Pharmaceuticals, LLC - Product Pipeline Review - 2014', provides an overview of the Iroko Pharmaceuticals, LLC's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Iroko Pharmaceuticals, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Iroko Pharmaceuticals, LLC including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Iroko Pharmaceuticals, LLC's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Iroko Pharmaceuticals, LLC's pipeline products Reasons to buy - Evaluate Iroko Pharmaceuticals, LLC's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Iroko Pharmaceuticals, LLC in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Iroko Pharmaceuticals, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Iroko Pharmaceuticals, LLC and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Iroko Pharmaceuticals, LLC - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Iroko Pharmaceuticals, LLC and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Iroko Pharmaceuticals, LLC Snapshot 5 Iroko Pharmaceuticals, LLC Overview 5 Key Information 5 Key Facts 5 Iroko Pharmaceuticals, LLC - Research and Development Overview 6 Key Therapeutic Areas 6 Iroko Pharmaceuticals, LLC - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Iroko Pharmaceuticals, LLC - Pipeline Products Glance 10 Iroko Pharmaceuticals, LLC - Late Stage Pipeline Products 10 Pre-Registration Products/Combination Treatment Modalities 10 Phase III Products/Combination Treatment Modalities 11 Iroko Pharmaceuticals, LLC - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Iroko Pharmaceuticals, LLC - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Iroko Pharmaceuticals, LLC - Drug Profiles 14 diclofenac nanoformulation 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 meloxicam nanoformulation 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 naproxen nanoformulation 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 celecoxib nanoformulation 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 IPNIB 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Iroko Pharmaceuticals, LLC - Pipeline Analysis 21 Iroko Pharmaceuticals, LLC - Pipeline Products by Target 21 Iroko Pharmaceuticals, LLC - Pipeline Products by Route of Administration 22 Iroko Pharmaceuticals, LLC - Pipeline Products by Molecule Type 23 Iroko Pharmaceuticals, LLC - Pipeline Products by Mechanism of Action 24 Iroko Pharmaceuticals, LLC - Recent Pipeline Updates 25 Iroko Pharmaceuticals, LLC - Dormant Projects 27 Iroko Pharmaceuticals, LLC - Locations And Subsidiaries 28 Head Office 28 Appendix 29 Methodology 29 Coverage 29 Secondary Research 29 Primary Research 29 Expert Panel Validation 29 Contact Us 30 Disclaimer 30
List of Tables Iroko Pharmaceuticals, LLC, Key Information 5 Iroko Pharmaceuticals, LLC, Key Facts 5 Iroko Pharmaceuticals, LLC - Pipeline by Indication, 2014 7 Iroko Pharmaceuticals, LLC - Pipeline by Stage of Development, 2014 8 Iroko Pharmaceuticals, LLC - Monotherapy Products in Pipeline, 2014 9 Iroko Pharmaceuticals, LLC - Pre-Registration, 2014 10 Iroko Pharmaceuticals, LLC - Phase III, 2014 11 Iroko Pharmaceuticals, LLC - Phase II, 2014 12 Iroko Pharmaceuticals, LLC - Preclinical, 2014 13 Iroko Pharmaceuticals, LLC - Pipeline by Target, 2014 21 Iroko Pharmaceuticals, LLC - Pipeline by Route of Administration, 2014 22 Iroko Pharmaceuticals, LLC - Pipeline by Molecule Type, 2014 23 Iroko Pharmaceuticals, LLC - Pipeline Products by Mechanism of Action, 2014 24 Iroko Pharmaceuticals, LLC - Recent Pipeline Updates, 2014 25 Iroko Pharmaceuticals, LLC - Dormant Developmental Projects,2014 27
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.